Psych Editorial
  • Home
  • Contact

Meet the Executive Eli Lilly and Company Leadership Team: Enrique Conterno

Meet the Executive Eli Lilly and Company Leadership Team: Enrique Conterno 

Enrique Conterno became president of Lilly Diabetes on November 1, 2009. With a heritage extending back to nearly 90 years ago when Lilly introduced the world’s first commercial insulin, Lilly Diabetes continues working to meet the diverse needs of people with diabetes. The business, which became operational in January 2010, features a growing portfolio of products representing the most important therapeutic areas of diabetes care.

Conterno is also a senior vice president for Eli Lilly and Company. Since January 2009, he had served as president of Lilly USA. He is a member of Lilly’s executive committee.

Born in Lima, Peru, Conterno earned a master’s of business administration degree at Duke University in 1992. He earned his bachelor’s degree in mechanical engineering from Case Western Reserve University in 1989.

Conterno joined Lilly as a sales representative in 1992. From 1993 to 1995, he held roles as a financial analyst, marketing associate, and business development manager. In 1996, Conterno became sales and marketing director for the Peru affiliate, and in 1998, he became the sales and marketing director for Lilly’s affiliate in Brazil. In 2000, Conterno was named executive director of marketing for the intercontinental region and Japan.

Conterno served as president and general manager for Lilly’s operations in Mexico in 2003, leading one of the company’s largest affiliates outside the U.S. In July 2006, he was named vice president of Lilly USA’s neuroscience business unit, and in June 2008, he became senior vice president for health care professional markets for Lilly USA.

Source: Eli Lilly and Co. Press Releases – Executive Bios

Related Posts

Takeda Pharmaceuticals

Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder

Eli Lilly and Co., Executive Bios

Meet the Executive Eli Lilly and Company Leadership Team: Fionnuala M. Walsh

Eli Lilly and Co., Executive Bios

Meet the Executive Eli Lilly and Company Leadership Team: Jacques Tapiero

News & Views

  • Now Accepting Content
  • Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder
  • Introducing the New Kid on the Block to Treat Depression: “Brintellix”.
  • Meet the Executive Eli Lilly and Company Leadership Team: Fionnuala M. Walsh
  • Meet the Executive Eli Lilly and Company Leadership Team: Jacques Tapiero
Psych Editorial
Copyright © PhysicianEditorial.com
All Rights Reserved!